Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is slated to report third-quarter 2025 results on Nov. 5, before the opening bell.

Abstract: The paper investigates the problem of passive target localization from a moving observer using bearing-only measurements. The following three estimation algorithms are considered: a ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Recursion Pharmaceuticals, Inc. before investing. In this article, we go over a ...

CNBC’s Jim Cramer answers calls from viewers and offers advice for their stock picks. Secret Service finds 17 'skimming' devices in tour of San Antonio businesses Trump just kneecapped the GOP’s ...